06.08.2025 – 11:05Helmholtz Munich2New Endoscopy Technology Enables Early Detection of Esophageal Cancermehr
24.07.2025 – 08:55Helmholtz MunichTherapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in PatientsLearn more about research at Helmholtz Munichmehr
14.07.2025 – 11:10Helmholtz Munich2New Label-Free Imaging Tracks Cancer Treatment in Single CellsLearn more about research at Helmholtz Munichmehr
24.06.2025 – 08:00Hagleitner Hygiene International GmbHGlobal Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Yearmehr
18.06.2025 – 14:00PNO Innovation GmbHLess than 30 days left to apply – don’t miss your chanceOpen CallEin Dokumentmehr
28.05.2025 – 08:31Helmholtz MunichAI Meets Game Theory: How Language Models Perform in Human-Like Social ScenariosNewsroommehr
22.04.2025 – 06:49Helmholtz MunichHelmholtz Launches Task Force to Strengthen Prevention Researchmehr
15.04.2025 – 14:00PNO Innovation GmbHcanSERV Open Call relaunches: Apply now for Free Access to Cutting-Edge Cancer Research ServicesOpen CallEin Dokumentmehr
25.03.2025 – 08:01PNO Innovation GmbHSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension TreatmentSGLT2 HYPE websitemehr
07.03.2025 – 07:31STADA Arzneimittel AG3Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the marketEin Dokumentmehr
20.02.2025 – 17:05Helmholtz MunichNew Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized DataVisit https://www.adiposetissue.org/mehr
14.01.2025 – 11:15Helmholtz MunichSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissuesmehr
09.01.2025 – 11:00Bosch Healthcare Solutions GmbHVivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergenciesmehr
19.12.2024 – 11:43RHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmehr
11.12.2024 – 14:03Helmholtz MunichMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025Read Interviewmehr
28.11.2024 – 15:22GEA Group AktiengesellschaftGEA launches Body Condition Scoring for cowsVisit GEA's press websiteEin Dokumentmehr
25.11.2024 – 13:52Helmholtz MunichInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmehr
14.11.2024 – 14:00PNO Innovation GmbHLast Call for canSERV Third Open Call FundingOpen CallEin Dokumentmehr
16.10.2024 – 14:00PNO Innovation GmbHEvent Announcement: VIROFIGHT Hybrid SymposiumRegister HereEin Dokumentmehr
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
17.09.2024 – 14:05PNO Innovation GmbHLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"Challenge CallEin Dokumentmehr
09.09.2024 – 09:06Sysmex Europe SE2Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.Visit our website!Ein Dokumentmehr
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBEin Dokumentmehr
03.09.2024 – 11:10Bosch Healthcare Solutions GmbHNear-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesiimehr
29.08.2024 – 14:03PNO Innovation GmbHcanSERV relaunches Open Call for Service ProvisionOpen CallEin Dokumentmehr
28.08.2024 – 07:34STADA Arzneimittel AGPress release: STADA continues strong growth journey in the first half of 2024Ein Dokumentmehr
18.07.2024 – 11:05Bosch Healthcare Solutions GmbHPCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling pointmehr